Valuation: Incyte Corporation

Market Cap 24.44B 21.17B 19.8B 18.09B 34.05B 2,329B 34.64B 232B 90.99B 1,166B 91.73B 89.76B 3,891B P/E 2026 *
53.8x
P/E 2027 * 16.8x
Enterprise Value 20.19B 17.49B 16.35B 14.95B 28.13B 1,924B 28.62B 191B 75.17B 963B 75.78B 74.15B 3,215B EV / Sales 2026 *
3.4x
EV / Sales 2027 * 2.98x
Free-Float
98.14%
Yield 2026 *
-
Yield 2027 * -
1 day+0.82%
1 week+1.70%
Current month+1.70%
1 month+2.56%
3 months+23.33%
6 months+11.48%
Current year+23.06%
1 week 115.77
Extreme 115.77
124.57
1 month 110.56
Extreme 110.56
132.6
Current year 89.25
Extreme 89.25
132.6
1 year 78.2
Extreme 78.2
132.6
3 years 50.27
Extreme 50.27
132.6
5 years 50.27
Extreme 50.27
132.6
10 years 50.27
Extreme 50.27
153.15
Manager TitleAgeSince
Chief Executive Officer 58 26/06/2025
Director of Finance/CFO 57 04/05/2026
President 62 05/06/2023
Director TitleAgeSince
Chairman 59 26/06/2025
Director/Board Member 72 20/01/2015
Director/Board Member 64 20/01/2015
Date Insider Type Main position Quantity % Market Cap.
03/08/26 Fiscal year

EVP & Chief Scientific Officer

18,165 0.0090%
31/07/26 Sell

Chairperson

-15,888 0.0078%
23/07/26 Free

Chief Technology Officer

15,425 0.0077%
Change 5-day change 1-year change 3-year change Capi.($)
+0.82%+1.70%+55.06%+85.80% 24.44B
+3.02%+5.96%+43.53%+2.86% 78.32B
+0.84%+5.66%-0.15%+27.88% 51.1B
+0.90%+0.99%+22.01%+176.13% 49.18B
+1.72%+9.27%-48.46%-48.80% 44.71B
-0.39%+2.06%+58.51%-23.65% 30.72B
+1.08%+9.10%+128.98%-41.26% 23.62B
+2.58%+12.23%+6.63%+202.17% 21.05B
-0.62%-4.29%+65.10%+117.79% 16.61B
+0.22%+5.72%+81.77%+167.35% 16.51B
Average +1.02%+4.15%+41.30%+66.63% 35.63B
Weighted average by Cap. +1.35%+4.28%+31.10%+49.12%

Financials

2026 *2027 *
Net sales 5.94B 5.15B 4.81B 4.4B 8.28B 566B 8.42B 56.35B 22.13B 283B 22.31B 21.83B 946B 6.26B 5.42B 5.07B 4.63B 8.72B 596B 8.87B 59.31B 23.29B 298B 23.48B 22.97B 996B
Net income 466M 403M 377M 345M 649M 44.37B 660M 4.42B 1.73B 22.21B 1.75B 1.71B 74.14B 1.47B 1.27B 1.19B 1.09B 2.05B 140B 2.08B 13.94B 5.48B 70.14B 5.52B 5.4B 234B
Net Debt -4.25B -3.68B -3.44B -3.15B -5.92B -405B -6.02B -40.29B -15.82B -203B -15.95B -15.61B -677B -5.81B -5.04B -4.71B -4.3B -8.1B -554B -8.24B -55.11B -21.64B -277B -21.82B -21.35B -926B
Logo Incyte Corporation
Incyte Corporation specializes in the research & development of therapeutic products mainly intended for the treatment of cancers and inflammatory disorders. Net sales break down by revenue source as follows: - product sales (84.7%); - royalties (12.4%); - income from research and cooperation agreements (2.9%).
Employees
2,844
Date Price Change Volume
10/08/26 $121.55 +0.82% 1,343,608
07/08/26 $120.56 +1.84% 1,540,373
06/08/26 $118.38 -1.19% 2,390,460
05/08/26 $119.80 -0.66% 1,795,673
04/08/26 $120.60 +1.83% 2,077,654
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
27
Last Close Price
120.56USD
Average target price
124.96USD
Spread / Average Target
+3.65%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. INCY Stock